PETER LICHT: Open Payments
NPI 1841267457 · NEWTOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 77 payments from 24 companies in 2025. Trend: 2023 $2,311 · 2024 $2,909 · 2025 $1,706
Food & beverage: $1,706
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $445 |
| ABBVIE INC. | 22 | $347 |
| Exact Sciences Corporation | 9 | $198 |
| Novo Nordisk Inc | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Corcept Therapeutics | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
Products named: BREZTRI, VRAYLAR, The Cologuard Plus Collection Kit, AIRSUPRA, QULIPTA, REXULTI, Kerendia, Ozempic.
Industry payments across CT — which companies pay providers there.
